[Results with new cytotoxic agents].
D002330:Carmustine / Q000009:adverse effects / Q000627:therapeutic use*; D003606:Dacarbazine / Q000009:adverse effects / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D012075:Remission, Spontaneous; D014226:Triazenes / Q000627:therapeutic use*
D014226:Triazenes; D003606:Dacarbazine; D002330:Carmustine